Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/13/2003WO2003064687A3 Prognostic and treatment methods relating to fibrotic liver disease
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003061363A3 Mutations caused by activation-induced cytidine deaminase
11/13/2003WO2003060470A3 Breast cancer expression profiling
11/13/2003WO2003060444A8 Method for detection of pathogenic microorganisms
11/13/2003WO2003057165A3 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
11/13/2003WO2003052140A3 High throughput analysis and detection of multiple target sequences
11/13/2003WO2003047738A3 Liquid interface configurations for automated patch clamp recording
11/13/2003WO2003045310A3 Digital assay
11/13/2003WO2003042353A3 Methods for detection of a target nucleic acid by capture using multi-subunit probes
11/13/2003WO2003040689A3 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
11/13/2003WO2003040391A3 Method for producing and identifying soluble protein domains
11/13/2003WO2003038059A3 Enzymatic manipulation of metal particle-bound dna
11/13/2003WO2003035671A3 Methods for detecting genetic haplotypes by interaction with probes
11/13/2003WO2003034034A9 Automated system and method for processing multiple liquid-based specimens
11/13/2003WO2003033732A3 Real-time detection of dna amplification products
11/13/2003WO2003033673A3 High-throughput transcriptome and functional validation analysis
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003031942A8 Reagents and methods useful for detecting diseases of the breast
11/13/2003WO2003031592A3 Gene markers for beef marbling and tenderness
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003027316A3 Methods of using 33751, a human potassium channel family member
11/13/2003WO2003027258A3 RECOMBINANT DNA PROCESSES USING A dNTP MIXTURE CONTAINING MODIFIED NUCLEOTIDES
11/13/2003WO2003023059A3 Method and kit for the diagnosis or treatment control of intestinal carcinoma
11/13/2003WO2003023058A3 Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids
11/13/2003WO2003018830A3 METHOD TO IDENTIFY MODULATORS FOR HUMAN 3α-HYDROXYSTEROID DEHYDROGENASE
11/13/2003WO2003018813A3 Ashbya gossypii enzymes
11/13/2003WO2003015703A3 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
11/13/2003WO2003014346A3 High-throughput dna-isolation and transfection for analysing the function of genes or genetic products
11/13/2003WO2003012119A3 Nucleic acid amplification method
11/13/2003WO2003008553A3 Proteins associated with cell growth, differentiation, and death
11/13/2003WO2003007886A3 Plant ion channels and methods
11/13/2003WO2003004605A3 Mesenchymal cells and osteoblasts from human embryonic stem cell
11/13/2003WO2003002755A3 Glaucoma treatments with reduced hyperpigmentation
11/13/2003WO2002102984A3 Hdac9 polypeptides and polynucleotides and uses thereof
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002099077A3 Methods and compositions related to tagging of membrane surface proteins
11/13/2003WO2002098358A3 Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
11/13/2003WO2002095058A9 Emission ratiometric indicators of phosphorylation
11/13/2003WO2002086448A3 Detection of microsatellite instability and its use in diagnosis of tumors
11/13/2003WO2002081630A3 Use of semenogelin in the diagnosis, prognosis and treatment of cancer
11/13/2003WO2002077609A3 Identification of compounds for the treatment or prevention of proliferative diseases
11/13/2003WO2002075609A3 Predicting metabolic stability of drug molecules
11/13/2003WO2002074903A3 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses
11/13/2003WO2002072888A3 Polymorphisms in the human cmoat gene and uses thereof
11/13/2003WO2002066681A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
11/13/2003WO2002066671A3 Improved method for detection of atp
11/13/2003WO2002064831A3 Single nucelotide polymorphisms of the seek1 gene associated withpsoriasis
11/13/2003WO2002064796A8 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
11/13/2003WO2002062825A3 Detection of polymorphisms in the human 5-lipoxygenase gene
11/13/2003WO2002061033A3 Transfection of human embryonic stem cells
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002056893A8 Novel receptors for $i(helicobacter pylori) and use thereof
11/13/2003WO2002014551A9 Bioluminescent methods for direct visual detection of environmental compounds
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
11/13/2003WO2001090419A9 Methods for genetic analysis of dna to detect sequence variances
11/13/2003WO2001090313A8 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
11/13/2003US20030213016 Cyclin D polynucleotides polypeptides and uses thereof
11/13/2003US20030213004 Composition comprising ribozyme/monoclonal antibody fusion protein for treating cell proliferative disorders; anticarcinogenic/antiproliferative agents
11/13/2003US20030212497 Relative rates of cytochrome p450 metabolism
11/13/2003US20030212263 Mammastatin sequence variant C
11/13/2003US20030212262 Human serine racemase
11/13/2003US20030212253 Comprises peptide which binds to fibrinogen and serves as a modulator of enzyme activity; for increasing the half- life of proteins and pro-drugs in circulation; for treatment of arteriosclerosis and emphysema
11/13/2003US20030212252 Comprises g-protein coupled receptor polypeptide, melanin-concentrating hormone receptor (MCH) for treating hypertension, diabetes, cancer, dyslipidemias, cardiovascular disease, gall stones and osteoarthritis
11/13/2003US20030212132 Determination binding of gabapentin to cells
11/13/2003US20030212032 Oligonucleotide N3'→P5' thiophosphoramidates: their synthesis and use
11/13/2003US20030212024 Compositions and methods for cell dedifferentiation and tissue regeneration
11/13/2003US20030212023 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
11/13/2003US20030212020 Antisense modulation of macrophage migration inhibitory factor expression
11/13/2003US20030212014 Methods fo treating conditions associated with insulin resistance with aicar, (5-amino-4-imidazole carboxamide riboside) and related compounds
11/13/2003US20030212003 Cathepsin Y for the development of a medicament for the treatment of pain
11/13/2003US20030211990 Central nervous system disorders; test kits
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211636 Determining dosage of drugs metabolized by cytochrome P450 such as 2-methoxy-5-trifluoromethoxy-benzyl)-(2-phenyl-piperidin-3-yl)-amine; antibodies
11/13/2003US20030211635 Biological material detecting articles of manufacture
11/13/2003US20030211633 Micropipette and dividedly injectable apparatus
11/13/2003US20030211625 Method and apparatus for non-invasive monitoring of blood substances using self-sampled tears
11/13/2003US20030211613 Methods of altering calcium transport
11/13/2003US20030211609 Antisense modulation of ara70 expression
11/13/2003US20030211593 Comprises polymerase with modified exonuclease activity for use as amplification tool in DNA replication reactions
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211569 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211566 Micromethod and device for rapid detection, enumeration and identification of entities
11/13/2003US20030211565 Comprises cytochromes bonded to 7-benzyloxyresorufin substrates; kits; electrophoresis
11/13/2003US20030211564 Comprises element for separating erythrocytes from plasma, a protease layer, and ketoamine oxidase signal producing system layer
11/13/2003US20030211563 Human testis specific serine/threonine kinase 1 & 2
11/13/2003US20030211562 Contacting sulfotransferase in reaction solution with sulfate donor, test agent, and polymeric sulfate acceptor that is readily separated from reaction solution, detecting amount of sulfate in polymeric sulfate acceptor that has been separated
11/13/2003US20030211561 Human oxalyl-CoA decarboxylase
11/13/2003US20030211560 Bioluminescent protease assay
11/13/2003US20030211559 Comprises composition for identifying therapeutic agents that inhibit proteolytic processing of amyloid precursor protein; treating nervous system disorders
11/13/2003US20030211552 Cyclic GMP dependent protien kinase as a chemotherapeutic target for antiprotozoal agents
11/13/2003US20030211548 Nonradioactive assay to monitor and quantify target-cell killing activities mediated by cytotoxic T lymphocytes
11/13/2003US20030211543 Screening clone pools for DNA sequences associated with preferential enzymatic activities
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211540 Treatment of insulin resistance
11/13/2003US20030211532 Methods and compositions for analyzing nucleic acids
11/13/2003US20030211531 Methods for discovering tumor biomarkers and diagnosing tumors
11/13/2003US20030211530 Developing receptor tyrosine kinase targeted antitumor regimen; anticarcinogenc agents
11/13/2003US20030211529 Human Eag2
1 ... 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 ... 3003